Surgeons voiced concern about the challenging blood supply shortage the world is experiencing, especially as hospitals in America have been experiencing a 70-90% blood shortage since the beginning of the COVID-19 pandemic. The BloodSTOP iX hemostat can completely solve this global crisis.
Burn and trauma surgeons were thrilled by our leading hemostatic technology, which controls bleeding under a minute, saves operation time, and has a 100% survival rate. Saving blood saves lives.
BloodSTOP iX promotes fast healing, is 100% biodegradable, and does not leave any residue behind. It reduces patients’ hospital stay, providing significant cost savings to hospitals and patients. We are pleased to see that BloodSTOP iX received huge attention at the ABA meeting.